SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001372514-24-000023
Filing Date
2024-03-15
Accepted
2024-03-15 07:00:32
Documents
5
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A kiora-preliminaryproxyxann.htm PRE 14A 973049
2 GRAPHIC chart-852b5d40b6194bd1a8da.jpg GRAPHIC 104526
3 KIORA LOGO kioralogoa.jpg GRAPHIC 36955
4 PROXYCARD1 proxy1a.jpg GRAPHIC 154847
5 PROXYCARD2 proxy2a.jpg GRAPHIC 92730
  Complete submission text file 0001372514-24-000023.txt   1510565
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36672 | Film No.: 24752438
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)